The quality of the UV-A device and riboflavin solution used in cross-linking procedures is paramount for achieving successful outcomes and minimizing potential side effects. When selecting a riboflavin solution, it is particularly important to choose formulations that do not cause corneal thinning. For the UV-A device, key considerations include an ergonomic design, homogeneous UV-A light delivery to the cornea, and adjustable time and energy parameters.